Enavate Sciences GP, LLC Q4 2024 Filing

Filed February 14, 2025

Portfolio Value

$139.2B

Holdings

5

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
UPBUPSTREAM BIO INC
2,459,703$40.4B29.04%
2
IMNMIMMUNOME INC
3,478,261$36.9B26.53%
3
ZBIOZENAS BIOPHARMA INC
3,761,359$30.8B22.12%
4
CAMPCAMP4 THERAPEUTICS CORP
3,785,802$19.8B14.19%
5
CMPXCOMPASS THERAPEUTICS INC
7,788,150$11.3B8.11%